Per the clinic, the patient experienced an infection at implant site, resulting in loss of osseointegration and fixture loss.Subsequently, the patient was treated with topical antibiotics and steroid for 3 days (date not reported).There are no plans to reimplant the patient with a new device as of the date of this report.
|
The reported adverse event is associated with a returned device; however, the provided clinical information was reviewed by the manufacturer and no specific device analysis is deemed necessary at this time.Previous product examinations have not showed any relationship between a product geometrical deviation and the reported clinical complication.Additionally, there are no indications that a product failure has contributed to the reported issue.Implant loss with baha implants can occur at any time following implantation.Known reasons for implant loss include lack of adequate bone quality/quantity, trauma, infection, generalised diseases and surgical complication.The report frequency for these complications is being monitored under cbas complaint and medical device reporting data monitoring plan and the status is updated on a monthly basis.This event is added to this monitoring.This report is submitted on june 12, 2023.
|